7
Total investments
4
Early stage
0
Mid stage
2
Late stage
9y
Years active
Portfolio
6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Jul 2026
We are a diverse, international angel network with long investment experience
and industry expertise who engage and contribute with more than capital.
❖ We invest our passion, experience and capital in supporting entrepreneurs
in selected sectors across the Nordics. We care deeply about the success of
our portfolio companies and are thrilled to support them in different
strategic or operational roles.
❖ Our Angels have extensive experience as investors, board members, C-suite
executives, sector and functional specialists, researchers and entrepreneurs
within both small and large organisations.
❖ We built deep investment knowledge through the evaluation of hundreds of
ventures and work consistently through networks, pitch events and searches
to maintain a high-quality deal flow.
❖ We offer tailor made structures to help family offices and small investment
firms diversify into unlisted stocks as well as syndication and crowd funding
structures to pool smaller tickets.
Board Member
May 2026
Mediqor AB (Sweden) is a digital health platform company focused on Arabic-speaking populations in MENA and globally. We develop scalable, mobile-first health products that help users navigate care journeys, access trusted information, and connect to relevant providers and services.
Flagship product: Mediqor Health App (launch planned for July 2026).
What we deliver:
- Consumer-grade UX built for trust and retention
- Medical-quality content and structured health flows
- AI-supported guidance and personalization (where compliant)
- Partnership-ready platform for providers and organizations
We welcome partnerships with clinics, provider networks, employers, insurers, and strategic investors.
Board Member
Mar 2024
Medtech4Health is a national Strategic Innovation Programme within medical technology. We work to implement more medical technological ideas and solutions in healthcare, and to create value for patients. To make this possible, we bring together stake holders in healthcare, academia and business in regional nodes and in different types of projects. Our aim is, through innovation, to streamline healthcare and strengthen the medical technology industry, nationally and internationally.
Angel Investor
Nov 2022
Angel investor network formed by seasoned entrepreneurs investing smart money.
Angel Investor
Nov 2021
LSI Beta - en ny satsning för investeringar i start-upbolag inom life science
Med de otroligt roliga erfarenheterna från LSI Alfa som snart har investerat hela sitt tillgängliga kapital i sju olika bolag startar vi LSI Beta. Vi har nu tagit in 10 miljoner SEK från ett 30-tal erfarna affärsänglar, som skall investeras i ca. 7 nya och spännande bolag under 2022.
Angel Investor
Dec 2020
LSI Alpha består av 20 delägare med bred erfarenhet inom entreprenörskap, tech och life science. Vi investerar i start-ups inom life science (seed) med såväl kapital som kompetens. LSI Alpha har en investeringskommitte bestående av 14 personer som strukturerat utvärderar potentiella bolag. Läs mer om vilka bolag vi söker här
https://www.lifescienceinvest.se/lsi-alpha/
Experience · 12 entries
All (12)
Investments (7)
Founder (2)
Board (3)
2026
Angel Investor
Jul 2026
We are a diverse, international angel network with long investment experience
and industry expertise who engage and contribute with more than capital.
❖ We invest our passion, experience and capital in supporting entrepreneurs
in selected sectors across the Nordics. We care deeply about the success of
our portfolio companies and are thrilled to support them in different
strategic or operational roles.
❖ Our Angels have extensive experience as investors, board members, C-suite
executives, sector and functional specialists, researchers and entrepreneurs
within both small and large organisations.
❖ We built deep investment knowledge through the evaluation of hundreds of
ventures and work consistently through networks, pitch events and searches
to maintain a high-quality deal flow.
❖ We offer tailor made structures to help family offices and small investment
firms diversify into unlisted stocks as well as syndication and crowd funding
structures to pool smaller tickets.
Board Member
May 2026
Mediqor AB (Sweden) is a digital health platform company focused on Arabic-speaking populations in MENA and globally. We develop scalable, mobile-first health products that help users navigate care journeys, access trusted information, and connect to relevant providers and services.
Flagship product: Mediqor Health App (launch planned for July 2026).
What we deliver:
- Consumer-grade UX built for trust and retention
- Medical-quality content and structured health flows
- AI-supported guidance and personalization (where compliant)
- Partnership-ready platform for providers and organizations
We welcome partnerships with clinics, provider networks, employers, insurers, and strategic investors.
2024
Board Member
Mar 2024
Medtech4Health is a national Strategic Innovation Programme within medical technology. We work to implement more medical technological ideas and solutions in healthcare, and to create value for patients. To make this possible, we bring together stake holders in healthcare, academia and business in regional nodes and in different types of projects. Our aim is, through innovation, to streamline healthcare and strengthen the medical technology industry, nationally and internationally.
Evaluator for Vinnova Calls
Mar 2024
Vinnova is Sweden’s innovation agency. Our mission is to promote sustainable growth by improving the conditions for innovation, as well as funding needs-driven research.
Vinnova’s vision is for Sweden to be a world-leading country in research and innovation, an attractive place in which to invest and conduct business. We promote collaborations between companies, universities, research institutes and the public sector. We do this by stimulating a greater use of research, by making long-term investment in strong research and innovation milieus and by developing catalytic meeting places. Vinnova’s activities also focus on strengthening international cooperation. In order to increase our impact, we are also dedicated to interacting with other research financiers and innovation-promoting organisations. Every year Vinnova invests about SEK 2 billion in various initiatives.
Vinnova is a Swedish government agency working under the Ministry of Enterprise, Energy and Communications and acts as the national contact agency for the EU Framework Programme for R&D. We are also the Swedish government’s expert agency within the field of innovation policy. Vinnova was founded in January 2001. About 200 people work here and we have offices in Stockholm and Brussels. Our Director General is Charlotte Brogren.
2022
Angel Investor
Nov 2022
Angel investor network formed by seasoned entrepreneurs investing smart money.
Show all 12 entries ↓
Investment activity
2017–2026 · 7 investments
Recent (last 2 years)Earlier
